State Street Corp lessened its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 0.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,479,596 shares of the conglomerate’s stock after selling 193,735 shares during the period. State Street Corp owned 3.80% of Danaher worth $7,647,211,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of DHR. Stevens Capital Management LP increased its holdings in shares of Danaher by 56.8% in the 3rd quarter. Stevens Capital Management LP now owns 2,694 shares of the conglomerate’s stock valued at $749,000 after acquiring an additional 976 shares during the period. Stifel Financial Corp increased its position in Danaher by 1.3% during the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after purchasing an additional 11,216 shares during the period. SWAN Capital LLC acquired a new position in Danaher during the third quarter worth $62,000. Quantinno Capital Management LP raised its position in Danaher by 10.7% in the third quarter. Quantinno Capital Management LP now owns 125,452 shares of the conglomerate’s stock worth $34,878,000 after acquiring an additional 12,090 shares in the last quarter. Finally, Royal London Asset Management Ltd. boosted its position in shares of Danaher by 4.3% during the 3rd quarter. Royal London Asset Management Ltd. now owns 328,667 shares of the conglomerate’s stock worth $91,376,000 after purchasing an additional 13,423 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on DHR shares. Stifel Nicolaus increased their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Raymond James lowered their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Evercore ISI boosted their price objective on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Barclays dropped their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research note on Thursday, October 31st. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $287.16.
Danaher Stock Performance
Shares of DHR stock opened at $236.26 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52 week low of $215.68 and a 52 week high of $281.70. The company’s fifty day simple moving average is $252.64 and its 200-day simple moving average is $258.91. The company has a market cap of $170.64 billion, a PE ratio of 45.09, a P/E/G ratio of 4.43 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the firm posted $2.02 earnings per share. The company’s revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher’s payout ratio is 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Best Stocks Under $5.00
- SCHD: A Core Addition to Your Dividend Investment Portfolio
- Quiet Period Expirations Explained
- ZJK Stock Skyrockets Following NVIDIA Partnership News
- Insider Trading – What You Need to Know
- Zscaler: A Textbook Buy-the-Dip Opportunity
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.